XLONSVCT
Market cap4mUSD
Nov 14, Last price
50.95GBP
Name
Seneca Growth Capital VCT PLC
Chart & Performance
Profile
Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | (2,398) -6.00% | (2,551) -212.53% | 2,267 56.45% | |||||||
Cost of revenue | 252 | 485 | 540 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (2,650) | (3,036) | 1,727 | |||||||
NOPBT Margin | 110.51% | 119.01% | 76.18% | |||||||
Operating Taxes | (2,749) | 2,096 | ||||||||
Tax Rate | 121.37% | |||||||||
NOPAT | (2,650) | (287) | (369) | |||||||
Net income | (2,671) -2.84% | (2,749) -231.15% | 2,096 61.60% | |||||||
Dividends | (791) | (700) | (727) | |||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 2,224 | 3,816 | 5,470 | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 146 | 168 | 516 | |||||||
Net debt | (13,318) | (18,641) | (18,270) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (459) | (481) | (288) | |||||||
CAPEX | ||||||||||
Cash from investing activities | (688) | (4,675) | (2,406) | |||||||
Cash from financing activities | 1,433 | 3,116 | 4,743 | |||||||
FCF | (2,650) | (287) | (369) | |||||||
Balance | ||||||||||
Cash | 1,455 | 5,065 | 7,105 | |||||||
Long term investments | 11,863 | 13,576 | 11,165 | |||||||
Excess cash | 13,438 | 18,769 | 18,157 | |||||||
Stockholders' equity | 299 | 9,666 | 7,025 | |||||||
Invested Capital | 16,739 | 8,985 | 11,254 | |||||||
ROIC | ||||||||||
ROCE | 9.45% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 28,232 | 16,231 | 20,118 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | (2,650) | (3,036) | 1,727 | |||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |